SV2A and Alzheimer disease: It has been shown that people with AD had significantly less SV2A binding in the hippocampus compared to cognitively normal participants according to SV2A PET using 11C-UCB-J, 18F-UCB-H, and 18F-SDM-8 (Chen et al., 2018; Bastin et al., 2020).